Toolkit for Coping with Depression for Cancer Survivors
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
Recruiting
N/A
Interventional Study
Depression
Cancer
Adolescent
Young Adult
Adult
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 15 – 39
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 208 (estimated)
- Sponsor
- East Carolina University · Other
Who this trial is looking for
This trial is looking for young adults and adolescents who have survived cancer and are dealing with symptoms of depression. Participants will use a digital tool designed to help manage their mental health.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 15 and 39 years old.
- I was diagnosed with cancer between the ages of 12 and 39.
- I completed my cancer treatment at least 1 month ago.
- I speak and write in English.
- I own a smartphone with a data plan.
You may not be able to join if
- I have a current diagnosis of severe or persistent mental illness.
- I have severe thoughts of suicide, including having a plan or intent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Our team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes one psychoeducation component and four components that are based on evidence-based interventions for depression. The goal of this study is to test which component or combination of components meaningfully contribute to improvements in …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age at enrollment (adolescents 15-17, emerging adults 18-25, young adults 26-39)
* Age at diagnosis (adolescents 12-17, emerging adults 15-25, young adults 15-39)
* Time since completion of treatment: 1 month to 5 years
* Language: Fluent in English (spoken and written)
* Tech…
Contacts